Member Info for tintin35

Dr Arron Tolley, Chief Executive Officer of Aptamer Group, commented: "This licensing agreement with Twist Bioscience represents a significant step forward in Aptamer's strategy to build a licensing-led revenue model. It validates the commercial potential of our binders in the NGS market and provides a structure that combines upfront payments with ongoing royalties, demonstrating how our platform can deliver sustainable and recurring income streams.

"By directly supplying Twist Bioscience with Optimer® reagents, we can ensure the high quality and performance standards while embedding our technology into their NGS portfolio. Twist Bioscience is recognised globally as a leader in synthetic DNA and sequencing tools, and its scale and established customer base provide an excellent route to market for our binders. With the NGS sector showing continued growth, this partnership positions Aptamer to participate in that growth alongside a proven market leader. We look forward to supporting Twist Bioscience in expanding its sequencing solutions and to building further licensing opportunities across our technology base."

Probably top slice a few grand for sweets then let it run

The additional budget was approved to fully cover planned capital projects in the year, make payments to the capital projects finalized, and for constructing the road and electric line to Tulu Kapi Gold Development joint project.

It will also be used to prevent and withstand natural and human made disaster in the country as well as to finance executive offices that face shortage of budget.

Some 16.99 billion birr of the total was obtained from International Development Association- World Bank, and the remaining sum in aid.

BOOOOOOOOOMMMMMM

Why would the regional and central government's want to give us the licences? Because they are both invested in TK FFS.......

I think we'll keep jq and flog the rest

Project finance continues to come together at the subsidiary level in preparation for all the parties to sign detailed definitive documentation, targeted for end-August 2025.

"At this exciting time for KEFI we have also seen major international gold investment institutions become KEFI shareholders, including Ruffer Gold, Konwave/Gold 2000 and Phoenix Gold Fund. The next few weeks are expected to deliver more material milestones and enable the full launch of Tulu Kapi. I look forward to providing further updates as appropriate."

ARABIAN-NUBIAN SHIELD

SIGNING DEFINITIVE DOCUMENTATION - target sign August

PROJECT FINANCE DRAWDOWNS - target start September

PROCUREMENT - target September

COMMUNITY RESETTLEMENT -brought forward 3 months to July

Kefi website Q&A

Q.:Any comments or explanations in respect of the £1M ASX junior buying a Hong Kong company which owns exploration licences near Tulu Kapi?

A.: We avoid comment on other companies, other than to quote their public warning of regulatory restrictions and potential title disputes.

Posted 11 July 2025

Upon signing the Tulu Kapi funding package, the syndicate of parties will have aligned on timetable and key milestones. Then KEFI will be solely responsible to manage to the agreed schedule rather than KEFI continuing to strive to assemble commitments from as yet uncommitted parties.

And this will have been made possible by a calmed-down working environment in Ethiopia.

Leadership style and management composition will then also need to adjust accordingly.Frankly, it will be a refreshing relief to the team to have formal contractual commitments from all parties to the agreed schedule as set out in an agreed project execution plan. and to wrap the process in the enlarged planned team will finally be both warranted and necessary.

Lastly , the plan this year has been to have documentation ready by end June for launch to trigger upon certifications being completed as soon as possible from that date. That is what is happening and we will obviously announce when that occurs.

Booom....

Questions

Q: If the community wants the project to have gone ahead already, why have you not moved them already?

A: It would have been illegal without simultaneously triggering the Project and its programs for all those people.

Q. When will you hold your next webinar?

A. We have elevated our disclosure plans (and shareholders expectations’ in respect thereof) way beyond regulatory requirements. Anything other than an RNS is not required from a regulatory viewpoint and anything “extra” like a webinar or a website Q&A is sometimes impossible because the Company is “pregnant with about-to-be-disclosed material information”.

And, of course, if the company informed shareholders that it is pregnant with undisclosed material information, that of itself is an unclear disclosure which is unfair and unhelpful to shareholders. It sometimes takes weeks for multiple significant counterparties to approve a KEFI RNS.

So…frankly it has been a frustrating struggle recently to slot in a webinar due to the large number of milestones to report in recent months in particular. We like being transparent with the Q&A and with Webinars but that enthusiasm must be tempered by regulatory rules and guidelines.

We’ll time the next Webinar after taking advice from the NOMAD in particular. It may be necessary to change its format and, for instance, invite one of the independent research analysts to present their refreshed deep-dive report (after meeting senior in-country management) and filter questions on sensitive areas.

Be that as it may… the main thing is to make progress and report formally as soon as possible.

What's the block listing rns about?

Banks sorted in February and full funding in March. This SP is ridiculously low so must be worth a punt.....

Parliament approves banking proclamation, allowing foreign banks to enter #Ethiopia’s financial sector

Ethiopia's Parliament has approved the long-awaited banking business proclamation, enabling foreign banks to enter the country’s financial sector. The law permits foreign banks to establish subsidiaries, open branches or representative offices, or acquire stakes in local banks, capping foreign strategic investors’ ownership at 40% and allowing an additional 7% to 10% for non-strategic foreign national investors. It also limits the combined shareholding of foreign nationals and foreign-owned Ethiopian organizations to 49%, ensuring the majority ownership remains Ethiopian.

Despite the liberalization, some MPs voiced concerns over the impact on local banks. Desalegn Chane of the National Movement of Amhara (#NaMA) remarked, “I don’t think the government is providing enough support for private banks to make them competitive in the market.” In response, Mamo Mihretu, governor of the National Bank of Ethiopia, assured lawmakers that while some banks face challenges, “these problems are under the control of the central bank.” Currently, 32 banks operate in Ethiopia, with the state-owned Commercial Bank of Ethiopia holding 21.5% of the total banking capital.

Ratification for AFC should be a breeze....

Loads more info

https://www.kefi-goldandcopper.com/investors/q-and-a

"Over the past year, we have made significant progress commercially and technically, under challenging market conditions. The Group has focused on three key aspects of our strategy, being 1. internal asset development, 2. regaining commercial traction and 3. cost discipline. We have rebuilt and expanded the pipeline over the year, demonstrating a positive trajectory in revenue recognition with 65% of the year's total revenue realised in the second half and increased our collaborations with top ten pharmaceutical partners. We have underscored the growing demand for Optimer technology and the rising recognition of our platform within the industry.

"Aptamer's strong technical delivery across both immunohistochemistry (IHC) and gene therapy delivery has been instrumental in driving commercial interest. The Group has secured an increasing number of contracts for Optimer IHC development, reinforcing our growing reputation in this segment of the market. In the drug delivery space, data generated internally facilitated the signing of a substantial contract for Optimer delivery vehicles for gene therapies and initiated a post-period collaboration with AstraZeneca to explore the use of our molecules for drug delivery in fibrotic liver disease.

"The Group's partnership with Unilever has made considerable progress towards the use of Optimer binders in treating malodour in deodorant products. Finally, a soft launch of our new Optimer+ platform has been well received across the industry, leading to two new contracts, one with a top ten pharmaceutical partner, in the first few months of launch. This provides us with a unique position within the market to continue progression.

looking good from here on. This was priced to fail so we ought to see significant improvement in the SP

You really can't guess?

Waiting for 22nd October with presentation which sounds hopeful